Search
Returning search results with filters:
Remove filter for
Category: Health products
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 15 of 467 items.
Incorrect dosing information on the “SAVE ME” instructional card in the Naloxone Take Home Kit by Canadian Hospital Specialties Ltd
AlertPublic advisory | 2024-07-26
Various multivitamins and supplements distributed across Canada are being recalled because they may contain metal fibres
AlertPublic advisory | 2024-07-26
Unauthorized drug products sold illegally on Quadragen and Advanced Research websites may pose serious health risks
AlertPublic advisory | 2024-07-19
Health Canada is warning Canadians about the potential risks of using homemade sunscreens
AlertPublic advisory | 2024-07-19
Unauthorized sexual enhancement products may pose serious health risks
AlertPublic advisory | 2024-07-11
Philips Respironics recalls several models of CPAP and BiLevel PAP machines and mechanical ventilators
AlertPublic advisory | 2024-07-05
Unauthorized Korean-labelled Festal Plus tablets, seized from GD Health Town in Coquitlam, B.C., may pose serious health risks
AlertPublic advisory | 2024-06-28
One lot of ratio-ECTOSONE (TEVA-ECTOSONE) 0.05% mild lotion recalled due to an impurity that may pose health risks
AlertPublic advisory | 2024-06-28
Unauthorized workout supplements may pose serious health risks
AlertPublic advisory | 2024-06-25
Poppers are unauthorized and may pose serious health risks
AlertPublic advisory | 2024-06-13
Important Safety and Efficacy Information on ALBRIOZA (sodium phenylbutyrate and ursodoxicoltaurine) – Market Withdrawal and Continued Restricted Access
AlertHealth professional risk communication | 2024-06-07
Accel-Ondansetron ODT, Mint-Betahistine and PMS-Pirfenidone tablets recalled due to data integrity concerns
AlertPublic advisory | 2024-06-07
Only absorbable threads authorized for cosmetic use should be used in thread lift procedures
AlertPublic advisory | 2024-06-06
Importation of USA-authorized Carbamazepine Extended-Release Tablets, USP 200 mg and 400 mg due to the current shortage of Canadian-authorized carbamazepine
AlertHealth professional risk communication | 2024-06-05